Biopharmaceutical company Vistagen Therapeutics (NASDAQ:VTGN), engaged in new generation of medicines having potential of going beyond standard current care for nervous system disorders, has confirmed appointment of Mary L. Rotunno, J.D. to the Board of Directors. Shawn Singh, Chief Executive Officer of VistaGen, appreciated Mary’s experience of over three decades in leadership commencing with serving …
Continue reading “Vistagen Therapeutics (NASDAQ:VTGN) Stock In Breakout: How to Trade Now?”